Dataset Information


The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.

ABSTRACT: A gold standard of antiviral vaccination has been the safe and effective live-attenuated 17D-based yellow fever virus (YFV) vaccines. Among more than 500 million vaccinees, only a handful of cases have been reported in which vaccinees developed a virulent wild type YFV infection. This efficacy is presumed to be the result of both neutralizing antibodies and a robust T cell response. However, the particular immune components required for protection against YFV have never been evaluated. An understanding of the immune mechanisms that underlie 17D-based vaccine efficacy is critical to the development of next-generation vaccines against flaviviruses and other pathogens. Here we have addressed this question for the first time using a murine model of disease. Similar to humans, vaccination elicited long-term protection against challenge, characterized by high neutralizing antibody titers and a robust T cell response that formed long-lived memory. Both CD4+ and CD8+ T cells were polyfunctional and cytolytic. Adoptive transfer of immune sera or CD4+ T cells provided partial protection against YFV, but complete protection was achieved by transfer of both immune sera and CD4+ T cells. Thus, robust CD4+ T cell activity may be a critical contributor to protective immunity elicited by highly effective live attenuated vaccines.

PROVIDER: S-EPMC4962991 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3170363 | BioStudies
| S-EPMC7067203 | BioStudies
| S-EPMC7157777 | BioStudies
| S-EPMC7289542 | BioStudies
| S-EPMC6262001 | BioStudies
| S-EPMC7697718 | BioStudies
| S-EPMC4811652 | BioStudies
2017-01-01 | S-EPMC5559630 | BioStudies
| S-EPMC4871483 | BioStudies
| S-EPMC4752603 | BioStudies